Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Fosfestrol |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Fosfestrol
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Danazol |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Danazol
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Norethisterone (Onc Adjacent) |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Norethisterone (Onc Adjacent)
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Sipuleucel-T |
Autologous Cellular Immunotherapy | Solid Tumour (Prostate) | ||
|
Molecule
Sipuleucel-T
Therapeutic Category
Cellular Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Autologous Cellular Immunotherapy |
||||
Nogapendekin Alfa Inbakicept |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Nogapendekin Alfa Inbakicept
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
Vusolimogene Oderparepvec |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Vusolimogene Oderparepvec
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
Bemarituzumab |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Bemarituzumab
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
Nimotuzumab (Head & Neck) |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Nimotuzumab (Head & Neck)
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
Zenocutuzumab |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Zenocutuzumab
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
Petosemtamab |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Petosemtamab
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
Sevabertinib |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Sevabertinib
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
Zongertinib |
Investigational Monoclonal / ADC Agent | Solid Tumour | ||
|
Molecule
Zongertinib
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
||||
FosfestrolHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
DanazolHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
Norethisterone (Onc Adjacent)Hormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
Sipuleucel-TCellular Therapy |
|
|
Therapeutic Category
Cellular Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Autologous Cellular Immunotherapy |
|
Nogapendekin Alfa InbakiceptTargeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|
Vusolimogene OderparepvecTargeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|
BemarituzumabTargeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|
Nimotuzumab (Head & Neck)Targeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|
ZenocutuzumabTargeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|
PetosemtamabTargeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|
SevabertinibTargeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|
ZongertinibTargeted Therapy (Investigational Antibody / ADC) |
|
|
Therapeutic Category
Targeted Therapy (Investigational Antibody / ADC)
Oncology Type
Solid Tumour
Drug Class / Mechanism
Investigational Monoclonal / ADC Agent |
|